Investigating the effect of ointment prepared from Myrtus communis L. and Colchicum automnale L. for the treatment of grade I and II internal hemorrhoids

Phase 3

Recruiting

• Conditions: grade I and II internal hemorrhoids.

• Registration Number: IRCT20221013056160N1
• Lead Sponsor: Applied Pharmaceutical Research Center, Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Clients with first and second grade hemorrhoids who have been diagnosed with clinical symptoms and confirmation from a general surgeon.
Patients should be in the age group of 17 to 70 years.
Hemorrhoids of the clients are not caused by systemic diseases such as hypertension.
Presence of hemorrhoid symptoms for at least more than 6 days
Ability to read and write

Exclusion Criteria

Use of systemic steroidal and non-steroidal anti-inflammatory drugs and analgesic treatments
The use of systemic steroidal and non-steroidal anti-inflammatory drugs and analgesic and anti-hemorrhoid treatments (for one month before the study) and the use of anticoagulant drugs.
The need for a surgical method to treat hemorrhoids (with the approval of a gastroenterologist and using clinical and colonoscopy tests)
Patients with problems such as anorectal abscess, fistula, tuberculosis, herpes, varicella (confirmed by clinical tests or colonoscopy)
Infectious inflammatory diseases of the digestive tract or colorectal cancer (according to the patient's statement)
Previous use of laser or use of phlebotonic medicine to treat hemorrhoids one week before entering the study (according to the patient's statement)
Participation in another interventional study

Study & Design

• Study Type: interventional
• Study Design: Not specified